Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_assertion type Assertion NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_head.
- NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_assertion wasGeneratedBy ECO_0000203 NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_provenance.
- NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_assertion wasDerivedFrom lhgdn-20090331 NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_provenance.
- NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_assertion SIO_000772 17593927 NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_provenance.
- NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_assertion evidence source_evidence_literature NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_provenance.
- NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_assertion description "[The median survival times for oxaliplatin-treated gastric cancer patients with Arg/Arg or Arg/Gln genotypes of XRCC1 gene were significantly longer than others (P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168813.RAC5LXfhbrRJJwvTlAqJovvpf9f4Sw1zzjBTamIs80VLs130_provenance.